| Metric | Q1 FY27 | Q4 FY26 | Q1 FY26 |
|---|---|---|---|
| Revenue from operations | 293.1 | 234.7 | 354.8 |
| Other income | 15.2 | 22.9 | 8.3 |
| Total income | 308.4 | 257.6 | 363.0 |
| Profit before exceptional items & tax | 105.9 | 87.1 | 122.9 |
| Profit before tax | 105.9 | 87.1 | 122.9 |
| Net profit | 78.3 | 64.3 | 91.2 |
| Operating margin | 34.3% | 33.8% | 33.9% |
A dash means the filing did not report that period; n/m means not meaningful (margin on near-zero revenue). Growth is not shown when either period was a loss. Operating profit excludes other income.
| Net profit, year on year | -14.10% |
|---|---|
| Net profit, quarter on quarter | +21.80% |
| Revenue, year on year | -17.40% |
| Operating profit, year on year | -23.90% |
| Operating profit, quarter on quarter | +52.40% |
BSE results filing, NSE: BLUEJET. Figures extracted from the filing.
Blue Jet Healthcare Ltd: key numbers
- Share price
- ₹570.65
- Market cap
- ₹9,899 Cr
- Revenue (annual)
- ₹947.3 Cr
- Net profit (annual)
- ₹247.8 Cr
- P/E (TTM)
- 42.1×Sector 50.4×
- Promoter holding
- 73.15%-6.66% QoQ
- FII holding
- 0.63%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Blue Jet Healthcare Ltd
All →Blue Jet Healthcare Annual General Meeting
Blue Jet Healthcare held its 58th AGM, approving audited financials, a Re 1.20 dividend, and director re-appointments. No material amendments were noted.
Blue Jet Healthcare Investor Presentation: Key Takeaways
Blue Jet Healthcare reported Q1 FY27 revenue of INR 293 crores (+25% QoQ) and EBITDA of INR 98 crores. Management highlighted a shift toward higher-value PI and API verticals alongside significant upcoming capex.
Blue Jet Healthcare Earnings Call Transcript: Key Takeaways
Blue Jet Healthcare reported Q1 FY27 revenue of ₹2,931mn, up 25% QoQ but down 17% YoY. Management is focusing on capacity expansion and forward integration into advanced contrast media intermediates.
Blue Jet Healthcare Investor Presentation: Key Takeaways
Blue Jet Healthcare reported Q1 FY27 Revenue of ₹2,931mn, up 25% QoQ but down 17.4% YoY. Strategy focuses on expanding R&D and CDMO adjacencies.
Blue Jet Healthcare Earnings Call: Key Takeaways
Blue Jet Healthcare reported FY26 revenue of ₹947cr (-8% YoY) and PAT margin of 26%. Management highlights transition from investment to commercialization phase via significant Vizag greenfield expansion.
Blue Jet Healthcare Earnings Call: Key Takeaways
Blue Jet Healthcare reported FY26 revenue of ₹9,473 mn with 31% EBITDA margin. Strong growth in Contrast Media was offset by declines in Pharma Intermediates & API due to customer inventory normalization.